|
- ICH Official web site : ICH
Founded 35 years ago and registered as a non-profit legal entity under Swiss law in 2015, ICH has finalised nearly 80 Guidelines that are applied by regulatory authorities around the world ICH has 25 members, 41 observers, and a network of close to 700 experts globally
- ICH Official web site : ICH
The ICH Harmonised Guideline was finalised under Step 4 in February 2002 This document is intended to address recommendations on the application of bracketing and matrixing to stability studies conducted in accordance with principles outlined in the main stability Guideline
- ICH Official web site : ICH
It includes the ICH medical terminology (MedDRA), the Common Technical Document (CTD) and the development of Electronic Standards for the Transfer of Regulatory Information (ESTRI)
- ICH Official web site : ICH
The ICH Harmonised Guideline was finalised under Step 4 in November 2003 This document provides a standardised procedure for post-approval safety data management and the guidance for gathering and reporting information
- ICH Official web site : ICH
The ICH Harmonised Guideline was finalised under Step 4 in November 2011 It replaces and combines the ICH S2A and S2B Guidelines The S2A Guideline on Guidance on Specific Aspects of Regulatory Genotoxicity Tests for Pharmaceuticals was finalised under Step 4 in July 1995
- ICH Official web site : ICH
In order to facilitate the implementation of the CTD General (M4) Guideline, the ICH Experts have developed a series of Q As The document which reached Step 4 of the ICH Process in June 2004, intends to clarify the key issues regarding the CTD
- ICH HARMONISED GUIDELINE GUIDELINE FOR GOOD CLINICAL PRACTICE E6(R3)
The objective of this ICH GCP Guideline is to provide a unified standard to facilitate the mutual acceptance of clinical trial data for ICH member countries and regions by applicable regulatory authorities
- ICH Official web site : ICH
You can explore in the below table the index of all ICH Guidelines, finalised or under development, on the topics of Quality, Safety, Efficacy and Multidisciplinary
|
|
|